Envista Holdings (NVST) Asset Writedowns and Impairment (2019 - 2026)
Envista Holdings (NVST) posted quarterly Asset Writedowns and Impairment of $4.4 million for Q2 2026, up 238.46% year-over-year from $1.3 million in Q2 2025, and down 39.73% quarter-over-quarter from $7.3 million in Q4 2025.
Envista Holdings (NVST) Asset Writedowns and Impairment (2019 - 2026) Analysis & Trends
Envista Holdings' Asset Writedowns and Impairment history runs 8 years deep, the most recent figure standing at $4.4 million for Q2 2026.
- In Q2 2026, Asset Writedowns and Impairment rose 238.46% year-over-year to $4.4 million; the TTM figure through Apr 2026 stood at $11.7 million (down 98.99% YoY), while the FY2025 annual figure was $9.5 million, down 46.93% from the prior year.
- Asset Writedowns and Impairment for Q2 2026 stood at $4.4 million, down from $7.3 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $1.2 billion in Q2 2024, with the low at -$3.3 million in Q4 2023.
- The 5-year median for Asset Writedowns and Impairment is $2.0 million (2023), against an average of $98.2 million.
- The sharpest annual moves came in 2023 and 2025: Asset Writedowns and Impairment slumped 466.67% in 2023, then jumped 284.21% in 2025.
- Envista Holdings' Asset Writedowns and Impairment stood at $900000.0 in 2022, then plunged by 466.67% to -$3.3 million in 2023, then jumped by 157.58% to $1.9 million in 2024, then surged by 284.21% to $7.3 million in 2025, then slumped by 39.73% to $4.4 million in 2026.
- Business Quant data shows NVST's Asset Writedowns and Impairment at $4.4 million in Q2 2026, $7.3 million in Q4 2025, and $1.3 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Envista Holdings | 4.40 Bn | 3.27 Bn | 407.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 1.40 Mn |
| Jul 3, 2026 | 1.40 Mn |
| Apr 3, 2026 | 4.40 Mn |
| Apr 3, 2026 | 4.40 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Mar 28, 2025 | 1.30 Mn |
| Mar 28, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Jun 28, 2024 | 1.15 Bn |
| Jun 28, 2024 | 1.15 Bn |
| Mar 29, 2024 | 4.50 Mn |
| Mar 29, 2024 | 4.50 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 900,000.00 |
| Dec 31, 2022 | 900,000.00 |